The NewStandard ceased publishing on April 27, 2007.

Womenâ€TMs groups: FDA caved on emergency contraceptive

by NewStandard Staff

May 10, 2004 – Women’s rights groups expressed outrage Friday at the Federal Drug Administration’s (FDA) decision to reject an application for over-the-counter sales of an emergency contraceptive. The FDA clarified that Barr Laboratories, the company that makes the Plan B contraceptive, could resubmit its application, if the company can provide more data about the drug’s safety for young women or if it can design a way to sell the drug over-the-counter only for women over the age of sixteen. The agency said it turned down the application because Barr did not provide enough data about the drug’s safety for young women. But women’s rights groups and many health experts accuse the FDA of caving in to pressure from conservative Republican lawmakers and fundamentalist women’s groups. The FDA’s own advisory panel, after reviewing research on the drug’s safety, had recommended overwhelmingly in December that to agency approve over-the-counter sales of Plan B without restrictions. Numerous drugs have been approved by the FDA for over-the-counter sales with even less information on child safety. Advocates of Plan B, including doctor’s groups, predict making the drug easier to access could drastically reduce the number of unintended pregnancies in the US.

Send to Friends Respond to Editors or Reporter

The NewStandard ceased publishing on April 27, 2007.

Recent contributions by NewStandard Staff: